Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4857 results found.

Example of search result explained

Ebglyss

Exceptional medication
  • Active ingredient(s):
    lebrikizumab
  • Manufactured by:
    Eli Lilly Canada Inc. (Lilly)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 125 mg/mL (2 mL) DIN : 2549131
    • Subcutaneous Injectable Solution (pen) 125 mg/mL (2 mL) DIN : 2549123

JAMP Lisdexamfetamine

Exceptional medication
  • Active ingredient(s):
    lisdexamfetamine (dimesylate)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Capsule 10 mg DIN : 2535122
    • Capsule 20 mg DIN : 2535130
    • Capsule 30 mg DIN : 2535149
    • Capsule 40 mg DIN : 2535157
    • Capsule 50 mg DIN : 2535165
    • Capsule 60 mg DIN : 2535173

Bylvay

Exceptional medication
  • Active ingredient(s):
    odevixibat
  • Manufactured by:
    Medison Pharma Canada Inc. (Medison)
  • Strength and dosage form:
    • Capsule 1200 mcg DIN : 2542692
    • Capsule 200 mcg DIN : 2542641
    • Capsule 400 mcg DIN : 2542676
    • Capsule 600 mcg DIN : 2542684

Xolair

Exceptional medication
  • Active ingredient(s):
    omalizumab
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    Subcutaneous Injection Powder 150 mg DIN : 2260565

Omlyclo

Exceptional medication
  • Active ingredient(s):
    omalizumab
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 150 mg/mL (1 mL) DIN : 2553813
    • Subcutaneous Injectable Solution syringe 150 mg/mL (0,5 mL) DIN : 2553805

Eugia-Pazopanib

Exceptional medication
  • Active ingredient(s):
    pazopanib hydrochloride
  • Manufactured by:
    EUGIA Pharma Inc. (EUGIA Ph)
  • Strength and dosage form:
    Tablet 200 mg DIN : 2552957

NB-Rivaroxaban

Exceptional medication
  • Active ingredient(s):
    rivaroxaban
  • Manufactured by:
    NB Pharma Inc. (NB Pharma)
  • Strength and dosage form:
    • Tablet 10 mg DIN : 2555115
    • Tablet 15 mg DIN : 2555123
    • Tablet 20 mg DIN : 2555131
    • Tablet 2.5 mg DIN : 2555107

JAMP Rivastigmine Capsules

Exceptional medication
  • Active ingredient(s):
    rivastigmine
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Capsule 1.5 mg DIN : 2552256
    • Capsule 3 mg DIN : 2552264
    • Capsule 4.5 mg DIN : 2552272
    • Capsule 6 mg DIN : 2552280

AG-Sitagliptin Hydrochloride / Metformin

Exceptional medication
  • Active ingredient(s):
    sitagliptin/metformin hydrochloride
  • Manufactured by:
    Angita Pharma Inc. (Angita)
  • Strength and dosage form:
    • Tablet 50 mg -1000 mg DIN : 2557746
    • Tablet 50 mg -500 mg DIN : 2557711
    • Tablet 50 mg -850 mg DIN : 2557738

JAMP Sitagliptin Hydrochloride / Metformin

Exceptional medication
  • Active ingredient(s):
    sitagliptin/metformin hydrochloride
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Tablet 50 mg -1000 mg DIN : 2556200
    • Tablet 50 mg -500 mg DIN : 2556189
    • Tablet 50 mg -850 mg DIN : 2556197
Page 141 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.